Persistent Basal Cell Hyperplasia is Associated with Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis

AbstractBackground & AimsAlthough eosinophil count is the standard used to monitor disease activity in patients with eosinophilic esophagitis (EoE), there are often disparities between patient-reported symptoms and eosinophil counts. We examined the prevalence of epithelial alterations, namely b...

Full description

Saved in:
Bibliographic Details
Published inClinical gastroenterology and hepatology Vol. 18; no. 7; pp. 1475 - 1482.e1
Main Authors Whelan, Kelly A, Godwin, Bridget C, Wilkins, Benjamin, Elci, Okan U, Benitez, Alain, DeMarshall, Maureen, Sharma, Medha, Gross, Jonathan, Klein-Szanto, Andres J, Liacouras, Chris A, Dellon, Evan S, Spergel, Jonathan M, Falk, Gary W, Muir, Amanda B, Nakagawa, Hiroshi
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AbstractBackground & AimsAlthough eosinophil count is the standard used to monitor disease activity in patients with eosinophilic esophagitis (EoE), there are often disparities between patient-reported symptoms and eosinophil counts. We examined the prevalence of epithelial alterations, namely basal cell hyperplasia (BCH) and spongiosis, among patients with inactive EoE (eosinophil counts below 15 following therapy) and aimed to determine whether maintenance of these changes in epithelial morphology are associated with persistent clinical findings. MethodsEsophageal biopsies of 243 patients (mean age, 16.9 years) undergoing routine endoscopy at the University of Pennsylvania were evaluated for epithelial BCH and spongiosis. Univariable analysis was used to calculate the association between epithelial changes and symptoms as well as endoscopic findings and peak eosinophil count. We validated our findings using data from a cohort of patients at the University of North Carolina. ResultsThe discovery and validation cohorts each included patients with inactive EoE, based on histologic factors, but ongoing BCH and spongiosis. Ongoing BCH, but not spongiosis, in patients with inactive EoE was associated with symptoms (odds ratio, 2.14; 95% CI, 1.03–4.42; P=.041) and endoscopic findings (odds ratio, 7.10; 95% CI, 3.12–16.18; P<.001). ConclusionsIn patients with EoE, the presence of BCH might indicate ongoing disease activity, independent of eosinophil count. This might account for the persistent symptoms in patients who are considered to be in remission based on histologic factors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Data analysis and interpretation: KAW, BCG, BJW, OUE, AJK-S, ESD, JMS, GEWF, ABM, HN
Clinical sample procurement: AJB, MD, GFW, ABM
KA Whelan and BC Godwin contributed equally to this work
Manuscript writing and editing: KAW, BCG, BJW, OUE, AJK-S, CAL, ESD, JMS, GWF, ABM, HN
Experimental Design and Execution: KAW, BCG, BJW, OUE, AJB, MD, MS, JG, AJK-S, ESD, GWF, ABM, HN
Author Contributions
ISSN:1542-3565
1542-7714
DOI:10.1016/j.cgh.2019.08.055